Evidence map›Paper›PMID 42541282›Full record

ArticleThe Lancet regional health. Western Pacific2026

National genomic survey of drug-resistance and multi-jurisdictional clusters of

Jessica R Webb, Eby Sim, Kristy Horan, Caitlin Selway, Patiyan Andersson, Susan Moss, Stanley Pang, Arnold Bainomugisa, Alireza Zahedi, Justin T Denholm and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Jessica R WebbDepartment of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Eby SimSydney Infectious Diseases Institute, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Kristy HoranMicrobiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.
Caitlin SelwayMicrobiology and Infectious Diseases, SA Pathology, Adelaide, South Australia, Australia.
Patiyan AnderssonMicrobiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.
Susan MossPublic and Environmental Health Reference Laboratories, Pathology Queensland, Queensland Department of Health, Brisbane, Queensland, Australia.
Stanley PangPathogen Genomics and Surveillance, PathWest Laboratory Medicine, Nedlands, Western Australia, Australia.
Arnold BainomugisaQueensland Mycobacterium Reference Laboratory, Pathology Queensland, Queensland, Australia.
Alireza ZahediPublic and Environmental Health Reference Laboratories, Pathology Queensland, Queensland Department of Health, Brisbane, Queensland, Australia.
Justin T DenholmVictorian Tuberculosis Program, Melbourne Health, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Elena MartinezNew South Wales Mycobacterium Reference Laboratory, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Sydney, New South Wales, Australia.
Sushil PandeyQueensland Mycobacterium Reference Laboratory, Pathology Queensland, Queensland, Australia.
Maria GlobanVictorian Mycobacterium Reference Laboratory (MRL), Victorian Infectious Diseases Reference Laboratory (VIDRL), at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Taryn CrightonNew South Wales Mycobacterium Reference Laboratory, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Sydney, New South Wales, Australia.
Ella M MeumannTerritory Pathology, Royal Darwin Hospital, Darwin, Australia.
Dimitrios MenouhosTerritory Pathology, Royal Darwin Hospital, Darwin, Australia.
Robert W BairdTerritory Pathology, Royal Darwin Hospital, Darwin, Australia.
Norelle L SherryMicrobiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.
Karina KennedyDepartment of Clinical Microbiology and Infectious Diseases, Canberra Health Services, Australian National University Medical School, Canberra, Australian Capital Territory, Australia.
Louise CooleyDepartment of Microbiology and Infectious Diseases, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Lex LeongMicrobiology and Infectious Diseases, SA Pathology, Adelaide, South Australia, Australia.
Clare SloggetDepartment of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Torsten SeemannDepartment of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Christopher CoulterQueensland Mycobacterium Reference Laboratory, Pathology Queensland, Queensland, Australia.
Amy V JennisonPublic and Environmental Health Reference Laboratories, Pathology Queensland, Queensland Department of Health, Brisbane, Queensland, Australia.
Vitali SintchenkoSydney Infectious Diseases Institute, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Benjamin P HowdenMicrobiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.
Australian Pathogen Genomics program

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tuberculosis is a global public health priority. In Australia, genomic analysis of Methods: Our national Findings: We analysed 6616 Mtb sequences, representing 59% of notified cases nationwide. Lineages 1-4 were detected, with lineage 2 the most prevalent and drug resistant. At the 5-SNP threshold, 373 genomic (17% of sequences) clusters were identified, with 48 (13%) clusters identified as nationally significant. Critically, 31 genomic clusters spanned multiple jurisdictions and persisted for >5 years. Genomic analysis inferred low rates of Interpretation: This first-of-a-kind study on genomic diversity of Funding: Australian National Health and Medical Research Council, Medical Research Futures Fund (FSPGN00049).

Indexed as

GenomicsPublic healthTuberculosis

Identifiers

PMID42541282
PMCPMC13427501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.